Takasago International Corporation
Notice Regarding Results of Tender Offer Application and Confirmation of Recorded Special Gains
The Company sold 444,038 shares of Hisamitsu Pharmaceutical Co., Inc. held, at 6,082 yen per share, totaling 2,700 million yen, and will record special gains of 2,543 million yen in the fiscal year ending March 2026.
Key Figures
- Number of Shares Sold: 444,038 shares (including shares held by Hisamitsu Pharmaceutical trading partner shareholders' association)
- Sale Price (per share): 6,082 yen
- Total Sale Amount: 2,700 million yen
AI要約
Overview of Tender Offer Application Results
The Company applied to the tender offer conducted by Taiyo Kosan Co., Ltd. for 444,038 ordinary shares of Hisamitsu Pharmaceutical Co., Inc. held (including shares held by the trading partner shareholders' association), and all shares were purchased. The sale price was 6,082 yen per share, with a total sale amount of 2,700 million yen. Settlement will commence from February 27, 2026.
Impact on Earnings and Future Outlook
Following the successful tender offer, the Company will record special gains of 2,543 million yen from the sale of investment securities in both the standalone and consolidated financial results for the fiscal year ending March 2026. Please note that the full-year consolidated earnings forecast for the fiscal year ending March 2026 was already disclosed in the “Notice of Revision to Earnings Forecast” dated February 13, 2026.
